Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
NuThrax (AV7909)
print preview
bookmark
share with colleague
General Information
Company
Emergent BioSolutions Inc.
Description
Third generation anthrax vaccine that consists of BioThrax, an adsorbed anthrax vaccine, and CPG 7909, an immunostimulatory compound
Molecular Target
Mechanism of Action
Latest Stage of Development
Phase II
Indication
Anthrax
Partner
Pfizer Inc.
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy